Ledger.Open graph →
SEC Form D · filed January 20, 2016

RespireRx Pharmaceuticals Inc

Offering
$2.5M
Sold
$100K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
GLEN ROCK, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Jeff E. Margolis · Glen Rock, NJExec · DirectorJames E. Sapirstein · Glen Rock, NJDirectorRobert N. Weingarten · Glen Rock, NJExec · DirectorArnold S. Lippa · Glen Rock, NJExec · DirectorKathryn E. Macfarlane · Glen Rock, NJDirectorRichard E. Purcell · Glen Rock, NJExecJames S. Manuso · Glen Rock, NJExec · DirectorSponsor Colony Hills Capital, LLC · Wilbraham, MADirectorGlenn R. Hanson · Wilbraham, MAExec · DirectorAmrit Shahzad · Beverly, MADirectorAndrew F. St Pierre · Burlington, MAExec · DirectorRobert N. Weingarten · Glen Rock, NJExec · DirectorArnold S. Lippa · Glen Rock, NJExec · DirectorKathryn E. Macfarlane · Glen Rock, NJDirectorRichard E. Purcell · Glen Rock, NJExecJames S. Manuso · Dublin, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗